Cargando…
Safety and preliminary efficacy of the Gam-COVID-Vac vaccine and outcomes of SARS-CoV-2 infection in Russian patients with genitourinary malignancies
BACKGROUND: To our knowledge, there is no clinical data pertaining to COVID-19 outcomes and safety of COVID-19 vaccination in Russian patients with genitourinary (GU) malignancies. Aim of our analysis was to describe the characteristics of the COVID-19 infection course as well as preliminary safety...
Autores principales: | Tsimafeyeu, Ilya, Volkova, Maria, Alekseeva, Galina, Berkut, Maria, Nosov, Alexander, Myslevtsev, Igor, Andrianov, Andrey, Semenov, Andrey, Borisov, Pavel, Zukov, Ruslan, Goutnik, Vadim, Savchuk, Sergey, Dengina, Natalia, Mitin, Timur |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590125/ https://www.ncbi.nlm.nih.gov/pubmed/34774086 http://dx.doi.org/10.1186/s13045-021-01205-z |
Ejemplares similares
-
COVID-19 in Patients With Renal Cell Carcinoma in the Russian Federation
por: Tsimafeyeu, Ilya, et al.
Publicado: (2021) -
Stereotactic body radiation therapy in combination with systemic therapy for metastatic renal cell carcinoma: a prospective multicentre study
por: Dengina, Natalia, et al.
Publicado: (2019) -
SUN-LB043 Phase 2 Randomized Study of the Efficacy and Safety of Testosterone in Metastatic Renal Cell Carcinoma Patients with Hypogonadism
por: Tishova, Yuliya, et al.
Publicado: (2019) -
Severe Persistent Eczema in a Recipient of the Gam-COVID-Vac vaccine
por: Ameri, Maryam, et al.
Publicado: (2022) -
Immune responses following the first dose of the Sputnik V (Gam-COVID-Vac)
por: Jeewandara, Chandima, et al.
Publicado: (2022)